Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Burak Kalin"'
Autor:
Burak Kalin, Elisabetta Metafuni, Mariëtte ter Borg, Rebecca Wijers, Eric Braakman, Cor H.J. Lamers, Andrea Bacigalupo, Jan J. Cornelissen
Publikováno v:
Haematologica, Vol 106, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/1ba70e80692641c3a6d607828dc364ea
Autor:
Burak Kalin, Mariëtte ter Borg, Rebecca Wijers, Judith A.E. Somers, Bronno van der Holt, Cornelis A.M. van Bergen, Eefke J. Petersen, Jurgen Kuball, Ellen Meijer, Nicolaas P.M. Schaap, Sacha S. Zeerleder, Annoek E. Broers, Eric Braakman, J.H. Frederik Falkenburg, Cor H.J. Lamers, Jan J. Cornelissen
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/ad6bd82989bf4efba299003556fa59bf
Autor:
Rebecca Wijers, Eric Braakman, Cor H. J. Lamers, Mariëtte N. D. Ter Borg, Burak Kalin, Andrea Bacigalupo, Jan J. Cornelissen, Elisabetta Metafuni
Publikováno v:
Haematologica
Haematologica, 106(2), 585-588. Ferrata Storti Foundation
Haematologica, 106(2), 585-588. Ferrata Storti Foundation
Autor:
Johan Maertens, Annoek E.C. Broers, Yvette van Norden, Mojca Jongen-Lavrencic, Gert J. Ossenkoppele, Michel van Gelder, Jan J. Cornelissen, Wendelien Zeijlemaker, Burak Kalin, Ellen Meijer, Dimitri Breems, Eric Braakman, Tim Grob
Publikováno v:
BLOOD ADVANCES, 4(18), 4430-4437. American Society of Hematology
Blood advances, 4(18), 4430-4437. American Society of Hematology
Kalin, B, van Norden, Y, van Gelder, M, Breems, D, Maertens, J, Jongen-Lavrencic, M, Broers, A E C, Braakman, E, Grob, T, Zeijlemaker, W, Ossenkoppele, G J, Meijer, E & Cornelissen, J J 2020, ' Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation ', BLOOD ADVANCES, vol. 4, no. 18, pp. 4430-4437 . https://doi.org/10.1182/BLOODADVANCES.2020002074
Blood Adv
Blood advances, 4(18), 4430-4437. The American Society of Hematology
Blood advances, 4(18), 4430-4437. American Society of Hematology
Kalin, B, van Norden, Y, van Gelder, M, Breems, D, Maertens, J, Jongen-Lavrencic, M, Broers, A E C, Braakman, E, Grob, T, Zeijlemaker, W, Ossenkoppele, G J, Meijer, E & Cornelissen, J J 2020, ' Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation ', BLOOD ADVANCES, vol. 4, no. 18, pp. 4430-4437 . https://doi.org/10.1182/BLOODADVANCES.2020002074
Blood Adv
Blood advances, 4(18), 4430-4437. The American Society of Hematology
Outcome after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is adversely affected by relapse to a considerable degree. To exploit the graft-versus-leukemia effect more effectively, we assessed the feasibility of early initiation of e
Autor:
Burak KALIN, Bahadir NAMDAR
Publikováno v:
Volume: 11, Issue: 1 56-73
Turkish Journal of Education
Turkish Journal of Education
This study investigates preservice science teachers' informal reasoning and scientific habits of mind about hydroelectric power plants. The sample of the study consists of 587 preservice science teachers who studied in four different universities in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdab3df0bad32e828102466e6d06c056
https://hdl.handle.net/11454/78142
https://hdl.handle.net/11454/78142
Autor:
Michel van Gelder, Jan J. Cornelissen, Avinash G. Dinmohamed, Gert J. Ossenkoppele, Otto Visser, Arjan A. van de Loosdrecht, Burak Kalin, Mojca Jongen-Lavrencic, Esther N. Pijnappel
Publikováno v:
Cancer Epidemiology, 57, 90-96. Elsevier
Cancer Epidemiology, 57, 90-96. ELSEVIER SCI LTD
Cancer Epidemiology, 57, 90-96. Elsevier BV
Kalin, B, Pijnappel, E N, van Gelder, M, Visser, O, van de Loosdrecht, A A, Ossenkoppele, G J, Cornelissen, J J, Dinmohamed, A G & Jongen-Lavrencic, M 2018, ' Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands ', Cancer Epidemiology, vol. 57, pp. 90-96 . https://doi.org/10.1016/j.canep.2018.09.007
Cancer Epidemiology, 57, 90-96. ELSEVIER SCI LTD
Cancer Epidemiology, 57, 90-96. Elsevier BV
Kalin, B, Pijnappel, E N, van Gelder, M, Visser, O, van de Loosdrecht, A A, Ossenkoppele, G J, Cornelissen, J J, Dinmohamed, A G & Jongen-Lavrencic, M 2018, ' Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands ', Cancer Epidemiology, vol. 57, pp. 90-96 . https://doi.org/10.1016/j.canep.2018.09.007
Background: The paucity of population-based research indicates that the application of intensive chemotherapy (ICT) among elderly acute myeloid leukemia (AML) patients, as well as their accrual to randomized controlled trials (RCTs) remains low for s
Autor:
Carlos Graux, Mojca Jongen-Lavrencic, Thomas Pabst, Harry C. Schouten, Jurjen Versluis, Jakob Passweg, Jeroen Janssen, Vincent H.J. van der Velden, Marie-Christiane Vekemans, Mels Hoogendoorn, Wendelien Zeijlemaker, Burak Kalin, Okke de Weerdt, Marie-Cecile Legdeur, Pierre W. Wijermans, Marinus van Marwijk Kooy, Bart J. Biemond, Markus G. Manz, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, J. Kuball, Mario Bargetzi, Bob Löwenberg, Jan J. Cornelissen
Publikováno v:
JCO Precision Oncology, 2017(1), 1-13. American Society of Clinical Oncology
JCO precision oncology, Vol. 1, no.1, p. 1-13 (2017)
JCO precision oncology, Vol. 1, no.1, p. 1-13 (2017)
Purpose The detection of minimal residual disease (MRD) in patients with acute myeloid leukemia (AML) may improve future risk-adapted treatment strategies. We assessed whether MRD-positive and MRD-negative patients with AML benefit differently from t
Autor:
Rebecca Wijers, Cor H. J. Lamers, Eefke Petersen, Burak Kalin, Nicolaas Schaap, Mariëtte N. D. Ter Borg, Eric Braakman, Cornelis A.M. van Bergen, Jan J. Cornelissen, J.H. Frederik Falkenburg, Sacha Zeerleder, Annoek E.C. Broers, Bronno van der Holt, Judith A.E. Somers, Jürgen Kuball, Ellen Meijer
Publikováno v:
HemaSphere, 3(5)
HemaSphere
HemaSphere, 3(5):e285. Wolters Kluwer Health
HemaSphere, 3(5):UNSP e285. Wolters Kluwer Health
HemaSphere, Vol 3, Iss 5 (2019)
Kalin, B, Ter Borg, M, Wijers, R, Somers, J A E, Van Der Holt, B, Van Bergen, C A M, Petersen, E J, Kuball, J, Meijer, E, Schaap, N P M, Zeerleder, S S, Broers, A E, Braakman, E, Frederik Falkenburg, J H, Lamers, C H J & Cornelissen, J J 2019, ' Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients : A Phase II Study Focusing on the Mechanism of Graft Predominance ', HemaSphere, vol. 3, no. 5, e285 . https://doi.org/10.1097/HS9.0000000000000285
HemaSphere
HemaSphere, 3(5):e285. Wolters Kluwer Health
HemaSphere, 3(5):UNSP e285. Wolters Kluwer Health
HemaSphere, Vol 3, Iss 5 (2019)
Kalin, B, Ter Borg, M, Wijers, R, Somers, J A E, Van Der Holt, B, Van Bergen, C A M, Petersen, E J, Kuball, J, Meijer, E, Schaap, N P M, Zeerleder, S S, Broers, A E, Braakman, E, Frederik Falkenburg, J H, Lamers, C H J & Cornelissen, J J 2019, ' Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients : A Phase II Study Focusing on the Mechanism of Graft Predominance ', HemaSphere, vol. 3, no. 5, e285 . https://doi.org/10.1097/HS9.0000000000000285
Publikováno v:
Stem Cell Investigation, 4:47. AME Publishing Company
Several parameters are involved in graft predominance after double umbilical cord blood transplantation (dUCBT), of which T-cell alloreactivity between the grafts is now considered to be the major denominator. We recently showed that alloreactive CD4
Autor:
Versluis J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kalin B; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Zeijlemaker W; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Passweg J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Graux C; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Manz MG; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Vekemans MC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Biemond BJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Legdeur MJC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kooy MVM; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., de Weerdt O; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Wijermans PW; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Hoogendoorn M; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Bargetzi MJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kuball J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Schouten HC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., van der Velden VHJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Janssen JJWM; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Pabst T; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Lowenberg B; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Jongen-Lavrencic M; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Schuurhuis GJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Ossenkoppele G; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Cornelissen JJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2017 Nov; Vol. 1, pp. 1-13.